National Comprehensive Cancer Network Moves Global Headquarters to Plymouth Meeting, PA

Food and Healthcare Press Releases Friday September 28, 2018 08:55
PLYMOUTH MEETING, Pennsylvania--28 Sep--PRNewswire/InfoQuest
  • New location just outside Philadelphia will accommodate expanding operations devoted to improving cancer care worldwide

Today, the National Comprehensive Cancer Network(R) (NCCN(R)) moved into new headquarters in Plymouth Meeting, PA, near Philadelphia. The nonprofit alliance of 27 leading academic cancer centers in the U.S. is moving from Fort Washington, PA. The new location will allow for greater hosting capacity for meetings, guests, and a growing staff.

"This new building is just one example of how NCCN is increasing our ability to address the diverse needs of people with cancer, and the clinicians who provide their care, all over the world," said Robert W. Carlson, MD, CEO, NCCN. "Our expanding capabilities allow us to do more every day to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives."

The NCCN Guidelines(R) detail the sequential management decisions and interventions for 97 percent of malignant cancers. In 2018, so far, the organization has added five new NCCN Guidelines(R), four new NCCN Guidelines for Patients(R), four NCCN Harmonized Guidelines for the Caribbean(TM), and is currently developing 17 additional NCCN Harmonized Guidelines for Sub-Saharan Africa(TM). There are now more than 160 international Adaptations and Translations of the NCCN Guidelines(R) available in 11 different languages at NCCN.org or via app.

"International surveys repeatedly show that oncologists worldwide are relying on NCCN Guidelines to stay up-to-date on the best evidence-based cancer care," Dr. Carlson continued. "By growing our global program, we're better able to meet the challenge of making NCCN Guidelines as useful as possible across various settings and circumstances."

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network(R) (NCCN(R)), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. Follow @NCCNnews on Twitter and @National.Comprehensive.Cancer.Network on Facebook.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

Latest Press Release

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens# FibroScan(R), Imposes Damages Orders Halt to Manufacturing and Sales

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky Medical,...

5 Ways to Set Healthy Grocery Shopping Habits in 2019

By Susan Bowerman, M.S., RD, CSSD, CSOWM, FAN, Senior Director, Worldwide Nutrition Education and Training Make your daily staples as healthy as you can. Small changes in the foods you eat every day can add up to big rewards. The holidays are over, and...

Related Topics